Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

The Search for Ebola Immune Response Targets

September 9, 2014 2:38 pm | News | Comments

The effort to develop therapeutics and a vaccine against the deadly Ebola virus disease (EVD) requires a complex understanding of the microorganism and its relationship within the host, especially the immune response. Read more...       

BI COPD Combo Excels in Phase 3

September 9, 2014 11:27 am | News | Comments

Boehringer Ingelheim presented the first data from the pivotal Phase 3 TONADO 1&2 studies (NCT01431274/NCT01431287) for the fixed-dose combination (FDC) of tiotropium plus olodaterol delivered via the Respimat inhaler in patients with moderate to very severe chronic obstructive pulmonary disease. Read more...

TOPICS:

Researchers ID New Genetic Target for a Different Kind of Cancer Drug

September 9, 2014 11:13 am | News | Comments

Researchers have discovered that the protein RBM4, a molecule crucial to the process of gene splicing, is drastically decreased in multiple forms of human cancer, including lung and breast cancers. Read more...            

TOPICS:
Advertisement

GSK Asthma Drug Hits Primary Endpoints in Two Key Trials

September 9, 2014 11:08 am | News | Comments

Results published in the New England Journal of Medicine (NEJM) and presented at the European Respiratory Society (ERS) congress provide further data from MENSA and SIRIUS, the two pivotal Phase 3 asthma studies of mepolizumab, an investigational IL-5 antagonist monoclonal antibody. Read more...

TOPICS:

Novartis Ultibro Breezhaler Superior in Reducing COPD Flare Ups

September 9, 2014 10:54 am | News | Comments

Novartis presented new data that demonstrated once-daily Ultibro Breezhaler was superior in reducing exacerbations and improving lung function compared to twice-daily Seretide Accuhaler, in patients with moderate-to-severe chronic obstructive pulmonary disease. Read more...

TOPICS:

UN Improves Operations After Staffers Get Ebola

September 9, 2014 10:47 am | by Maria Cheng, AP Medical Writer | News | Comments

World Health Organization staffers battling an Ebola outbreak in Sierra Leone now have better working conditions - including larger, more private quarters - after one of their scientists was infected with the deadly virus. Read more...     

TOPICS:

New Extractor Optimized for Processing Medicinal Marijuana

September 9, 2014 9:30 am | by Dr. Kenneth James, Supercritical Fluid Technologies, Inc. | Articles | Comments

The need for pharmaceutical grade cannabis oil has increased as researchers continue to investigate its use for the treatment of various ailments such as muscle spasms, glaucoma, nausea, mood and behavioral disorders, sleep disorders and chronic pain. Read more...

TOPICS:

Mast's AIR001 Promising in Phase 2

September 8, 2014 3:16 pm | News | Comments

Mast Therapeutics Inc. reported top-line results from a Phase 2 study of AIR001 (sodium nitrite) inhalation solution for the treatment of pulmonary arterial hypertension (PAH). Read more...                 

TOPICS:
Advertisement

Gilead, GSK Combo Drug Promising as PAH Treatment

September 8, 2014 3:14 pm | News | Comments

Gilead Sciences Inc. announced results from the AMBITION study, which was conducted in collaboration with GlaxoSmithKline (GSK). Read more...                                

TOPICS:

Scientists Reveal Cell Secret Potentially Useful for Vaccines

September 8, 2014 3:00 pm | News | Comments

The best defense is a good offense, especially when it comes to the immune system. The troops that respond to an infection are split into two squadrons, and, until recently, it seemed that the two were independent, without much interaction. Read more...

TOPICS:

Mayo Clinic, IBM Task Watson to Improve Clinical Trials

September 8, 2014 2:50 pm | News | Comments

Mayo Clinic and IBM announced plans to pilot Watson, the IBM cognitive computer, to match patients more quickly with appropriate clinical trials, beginning with research studies in cancer. Read more...              

TOPICS:

FTC Sues AbbVie, Teva Over Generic AndroGel

September 8, 2014 2:34 pm | News | Comments

The Federal Trade Commission is suing drugmakers AbbVie and Teva, saying they conspired to temporarily keep generic versions of AbbVie's low-testosterone drug AndroGel off the market. Read more...               

TOPICS:

Parkinson's, Cancer Findings Earn Medical Prizes

September 8, 2014 1:30 pm | by Malcolm Ritter, AP Science Writer | News | Comments

Key discoveries about breast cancer, Parkinson's disease and the body's handling of defective proteins have earned prestigious medical awards for five scientists. Read more...                     

TOPICS:

J&J, Janssen Partner with University of Toronto on Brain Treatments

September 8, 2014 11:16 am | News | Comments

The University of Toronto announced a new strategic open innovation collaboration with Janssen Inc. facilitated by the Johnson & Johnson Innovation center of California that will support research through the Collaborative Center for Drug Research (CCDR). Read more...

TOPICS:

AZ's COPD Drug Gets Mixed Results in Phase 2a

September 8, 2014 11:11 am | News | Comments

AstraZeneca announced that a Phase 2a study evaluating its novel investigational monoclonal antibody benralizumab in patients with COPD did not meet the primary endpoint, but that benralizumab demonstrated clinically significant improvements in lung function in the overall population. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading